Search clinical trials for: Benign Prostate Hyperplasia

Total 8995 results

AEterna Zentaris

Terminated

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

United States, Canada, Bulgaria, Germany
Health Ever Bio-Tech Co., Ltd.

Completed

Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS_LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Taiwan
Boston Scientific Corporation

Completed

PROMUS Element Plus US Post-Approval Study

Coronary Artery Disease

United States
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
Brooklyn Urology Research Group
American Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

United States
Fundacion Miguel Servet

Completed

Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Transurethral Resection of Prostate | Artery Embolization

Spain
Salzburger Landeskliniken

Unknown

Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate

Benign Prostatic Hyperplasia | Bladder Outlet Obstruction

Austria, Switzerland
Olympus Corporation of the Americas
Loma Linda University; VA Greater Los Angeles Healthcare System

Terminated

Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode

Benign Prostatic Hyperplasia

United States
Changhai Hospital

Unknown

Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship

Prostatic Neoplasms | Benign Prostatic Hyperplasia | Digital Rectal Examination

China
St. Louis University

Withdrawn

Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Incontinence, Urge | Nocturia | Incontinence, Urinary | Urinary Frequency/Urgency

United States
JW Pharmaceutical

Completed

Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System (CV)

Benign Prostatic Hyperplasia

Korea, Republic of
Rennes University Hospital

Completed

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers (CANARI)

Benign Prostate Hyperplasia

France
St. Joseph's Healthcare Hamilton
Ontario Ministry of Health and Long Term Care

Completed

PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate (PVP)

Benign Prostatic Hyperplasia

Canada
Cairo University

Completed

Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Ultrasonography | Male | Botulinum Toxins, Type A | Injection; Complications, Infection

Egypt
NeoTract, Inc.

Completed

BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia (BPH-6)

Benign Prostatic Hyperplasia

Denmark, United Kingdom, Germany
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
University of Washington
GlaxoSmithKline; VA Office of Research and Development; Seattle Institute for... and other collaborators

Completed

TRADE-Testosterone Replacement and Dutasteride Effectiveness (TRADE)

Benign Prostatic Hyperplasia | Hypogonadism

United States
Yuyu Pharma, Inc.

Completed

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

Benign Prostatic Hyperplasia

Korea, Republic of
PROCEPT BioRobotics

Completed

AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia (ABS)

Benign Prostatic Hyperplasia

India
University of Helsinki

Completed

KTP Green Light Prostatectomy Compared With Open Prostatectomy

BPH (Benign Prostatic Hyperplasia)

Finland
PROCEPT BioRobotics

Completed

Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia (AHA)

Benign Prostatic Hyperplasia

India
University of Helsinki
University of Turku; Oulu University Hospital; Tampere University; South Ostrobothnia...

Completed

KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)

BPH (Benign Prostatic Hyperplasia)

Finland
PROCEPT BioRobotics

Completed

Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II (AHA II)

Benign Prostatic Hyperplasia

India
University of Alberta
Merck Frosst Canada Ltd.

Withdrawn

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia

Canada
John D Louie

Withdrawn

Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Prostatic Hyperplasia

United Kingdom
University of North Carolina, Chapel Hill

Completed

Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Lumenis Be Ltd.

Unknown

Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH

Treatment of Benign Prostatic Hyperplasia

United States
University Hospital, Bordeaux

Completed

A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy (PROTOX)

Prostatic Hyperplasia

France
GlaxoSmithKline

Completed

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

Prostatic Hyperplasia

United States
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Benign Prostatic Hyperplasia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects

Benign Prostatic Hypertrophy (BPH)

Korea, Republic of
GlaxoSmithKline

Completed

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.

Prostatic Hyperplasia

United States
I.M. Sechenov First Moscow State Medical University

Completed

ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH

Lower Urinary Tract Symptoms | Prostatic Hyperplasia, Benign | Prostate Adenoma
ClinSearch
Biocompatibles UK Ltd; European Georges Pompidou Hospital

Unknown

Prostate Embolization for Acute Urinary Retention Study (PARIS1)

Prostatic Hypertrophy, Benign

France
GlaxoSmithKline

Completed

ARI103094-Follow-Up Study for REDUCE Study Subjects

Neoplasms, Prostate

France, Germany, Spain, United States, Netherlands, Canada, United Kingdom, Finland, Chile, Sweden, Argentina, Greece
GlaxoSmithKline

Completed

Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan

Prostatic Hyperplasia
GlaxoSmithKline

Completed

AVODART(Dutasteride) Post-marketing Surveillance(PMS) (AVO PMS)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

Korea, Republic of
Eli Lilly and Company
Nippon Shinyaku Co., Ltd.

Completed

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Benign Prostatic Hyperplasia

Japan
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

Erectile Dysfunction | Benign Prostate Hyperplasia

China
GlaxoSmithKline

Completed

Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Economic Analyses of the REDUCE Trial

Cancer | Benign Prostatic Hyperplasia | Neoplasms, Prostate
GlaxoSmithKline

Completed

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Korean Practice Patterns for Screening PCA(Prostate Cancer) (RESPECT)

Benign Prostatic Hyperplasia | Prostate Cancer | Neoplasms, Prostate

Korea, Republic of
Ausio Pharmaceuticals, LLC

Completed

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, India
GlaxoSmithKline

Completed

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

Benign Prostatic Hyperplasia
Kocatepe University

Completed

The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

Benign Prostatic Hyperplasia | Choroid Disease | Pupil Anomaly
Sophiris Bio Corp

Completed

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (PLUS-1)

Benign Prostatic Hyperplasia

United States, Australia, Canada, Russian Federation, Ukraine, New Zealand

Search clinical trials for: Benign Prostate Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations